Ledger.Open graph →
SEC Form D · filed February 26, 2016

NovaBay Pharmaceuticals, Inc

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
EMERYVILLE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Massimo E. Radaelli · Emeryville, CADirectorThomas J. Paulson · Emeryville, CAExecT. A. Mcpherson · Emeryville, CADirectorMark M. Sieczkarek · Emeryville, CAExec · DirectorJustin M. Hall · Emeryville, CAExecXinzhou (Paul) E. Li · Emeryville, CADirectorPaul E. Freiman · Emeryville, CADirectorGail J. Maderis · Emeryville, CADirectorPeter R. Mcdermott · Denver, COExecHal R. Shaw · Denver, CODirectorStephen Campbell · PHOENIX, AZDirectorIan F. Kennedy · NEWPORT BEACH, CAExec · DirectorThomas J. Paulson · Emeryville, CAExecSteven S. Siegel · Denver, CODirectorMijia A. Wu · Emeryville, CADirectorRoy J. Wu · Emeryville, CAExecXiaoyan A. Liu · Emeryville, CADirectorPeter F. Palmedo · Sun Valley, IDExec · DirectorTimothy Baldwin · PHOENIX, AZDirectorShawn K. O'Neill · Menlo Park, CAExecVivek Jayan · Fremont, CADirectorJayan Ramankutty · Fremont, CADirectorCarl J. Schramm · New York, NYExecParthasarathy Krishnan · New York, NYDirectorGavriel J. Ralbag · New York, NYDirectorMijia A. Wu · Emeryville, CADirectorRoy J. Wu · Emeryville, CAExecXiaoyan A. Liu · Emeryville, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗